COMPARISON OF ETEST AND NATIONAL-COMMITTEE-FOR-CLINICAL-LABORATORY-STANDARDS BROTH MACRODILUTION METHOD FOR ANTIFUNGAL SUSCEPTIBILITY TESTING - ENHANCED ABILITY TO DETECT AMPHOTERICIN B-RESISTANT CANDIDA ISOLATES

被引:168
作者
WANGER, A
MILLS, K
NELSON, PW
REX, JH
机构
[1] UNIV TEXAS,SCH MED,CTR INFECT DIS,DEPT INTERNAL MED,HOUSTON,TX 77030
[2] AB BIODISK NA,PISCATAWAY,NJ
关键词
D O I
10.1128/AAC.39.11.2520
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The National Committee for Clinical Laboratory Standards (NCCLS) proposed macrobroth reference method (M27P) for susceptibility testing of yeasts is technically difficult, We evaluated Etest, a simple agar-based MTC methodology, as a possible alternative. In studies of six yeast quality control strains, Etest yielded results identical to those obtained by the NCCLS reference method for both amphotericin B and fluconazole. In studies of 91 clinical Candida isolates, agreement +/- 2 dilutions between the two methods was 95% for fluconazole with phosphate-buffered RPMI 1640 agar and 96 to 97% for amphotericin B with either MOPS (morpholinepropanesulfonic acid)-buffered RPMI 1640 agar or antibiotic medium 3 agar. While the two methods had excellent general agrement, testing of a collection of amphotericin B-resistant isolates demonstrated that, unlike the NCCLS reference method, Etest readily identified the resistant isolates and could do so with a defined medium. Etest is equivalent to the NCCLS proposed method for susceptibility testing of yeasts and superior in its ability to detect amphotericin B resistance.
引用
收藏
页码:2520 / 2522
页数:3
相关论文
共 12 条
  • [1] ANIASSIE EJ, 1994, J INFECT DIS, V170, P384
  • [2] COMPARISON OF E-TEST AND NATIONAL-COMMITTEE-FOR-CLINICAL-LABORATORY-STANDARDS BROTH MACRODILUTION METHOD FOR AZOLE ANTIFUNGAL SUSCEPTIBILITY TESTING
    COLOMBO, AL
    BARCHIESI, F
    MCGOUGH, DA
    RINALDI, MG
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (03) : 535 - 540
  • [3] COLLABORATIVE COMPARISON OF BROTH MACRODILUTION AND MICRODILUTION ANTIFUNGAL SUSCEPTIBILITY TESTS
    ESPINELINGROFF, A
    KISH, CW
    KERKERING, TM
    FROMTLING, RA
    BARTIZAL, K
    GALGIANI, JN
    VILLAREAL, K
    PFALLER, MA
    GERARDEN, T
    RINALDI, MG
    FOTHERGILL, A
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (12) : 3138 - 3145
  • [4] ETEST FOR ANTIFUNGAL SUSCEPTIBILITY TESTING OF YEASTS
    ESPINELINGROFF, A
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1994, 19 (04) : 217 - 220
  • [5] SELECTION OF CANDIDATE QUALITY-CONTROL ISOLATES AND TENTATIVE QUALITY-CONTROL RANGES FOR IN-VITRO SUSCEPTIBILITY TESTING OF YEAST ISOLATES BY NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS PROPOSED STANDARD METHODS
    PFALLER, MA
    BALE, M
    BUSCHELMAN, B
    LANCASTER, M
    ESPINELINGROFF, A
    REX, JH
    RINALDI, MG
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (07) : 1650 - 1653
  • [6] QUALITY-CONTROL GUIDELINES FOR NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS RECOMMENDED BROTH MACRODILUTION TESTING OF AMPHOTERICIN-B, FLUCONAZOLE, AND FLUCYTOSINE
    PFALLER, MA
    BALE, M
    BUSCHELMAN, B
    LANCASTER, M
    ESPINELINGROFF, A
    REX, JH
    RINALDI, MG
    COOPER, CR
    MCGINNIS, MR
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (05) : 1104 - 1107
  • [7] DETECTION OF AMPHOTERICIN B-RESISTANT CANDIDA ISOLATES IN A BROTH-BASED SYSTEM
    REX, JH
    COOPER, CR
    MERZ, WG
    GALGIANI, JN
    ANAISSIE, EJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (04) : 906 - 909
  • [8] ANTIFUNGAL SUSCEPTIBILITY TESTING
    REX, JH
    PFALLER, MA
    RINALDI, MG
    POLAK, A
    GALGIANI, JN
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1993, 6 (04) : 367 - 381
  • [9] ANTIFUNGAL SUSCEPTIBILITY TESTING OF ISOLATES FROM A RANDOMIZED, MULTICENTER TRIAL OF FLUCONAZOLE VERSUS AMPHOTERICIN-B AS TREATMENT OF NONNEUTROPENIC PATIENTS WITH CANDIDEMIA
    REX, JH
    PFALLER, MA
    BARRY, AL
    NELSON, PW
    WEBB, CD
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (01) : 40 - 44
  • [10] Sanchez ML., 1992, ANTIM NEWSL, V8, P1, DOI [10.1016/0738-1751(92)90015-3, DOI 10.1016/0738-1751(92)90015-3]